Literature DB >> 8980113

Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins.

K Kino1, Y Taguchi, K Yamada, T Komano, K Ueda.   

Abstract

The human MDR1 gene encodes the multidrug transporter P-glycoprotein (Pgp). Although the MDR2/Pgp shares about 80% identity at the amino acid level with the MDR1/Pgp, the MDR2/Pgp cannot act as a multidrug transporter. We examined the drug sensitivity of Saccharomyces cerevisiae expressing either the human MDR1/Pgp or MDR2/ Pgp. The human MDR1/Pgp conferred about 4-fold resistance to aureobasidin A, a cyclic depsipeptide antifungal antibiotic, on the drug-sensitive yeast strains. Interestingly the human MDR2/Pgp also conferred about 2.5-fold resistance to aureobasidin A. The resistance to aureobasidin A conferred by the MDR2/Pgp as well as by the MDR1/Pgp was overcome by vinblastine, verapamil, and cyclosporin A, depending on their concentrations, but not by colchicine. Aureobasidin A probably interacts directly with Pgps, because it overcame multidrug resistance of human cells and inhibited azidopine photoaffinity labeling of MDR1/Pgp in human cell membranes. These results suggest the possibility that the human MDR1 and MDR2/Pgps have conserved domain(s) for drug recognition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980113     DOI: 10.1016/s0014-5793(96)01265-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Role of ABC transporters in aureobasidin A resistance.

Authors:  A Ogawa; T Hashida-Okado; M Endo; H Yoshioka; T Tsuruo; K Takesako; I Kato
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A.

Authors:  Peter G M Wuts; Lloyd J Simons; Brian P Metzger; Rachel C Sterling; Jerry L Slightom; Ake P Elhammer
Journal:  ACS Med Chem Lett       Date:  2015-04-23       Impact factor: 4.345

3.  Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi.

Authors:  Juliana M Figueiredo; Wagner B Dias; Lucia Mendonça-Previato; José O Previato; Norton Heise
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

4.  Inhibitory effect of aureobasidin A on Toxoplasma gondii.

Authors:  Sabrina Sonda; Giusy Sala; Riccardo Ghidoni; Andrew Hemphill; Jean Pieters
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 5.  Preface: the concept and consequences of multidrug resistance.

Authors:  Jonathan A Sheps; Victor Ling
Journal:  Pflugers Arch       Date:  2006-07-22       Impact factor: 3.657

Review 6.  Cholesterol fill-in model: mechanism for substrate recognition by ABC proteins.

Authors:  Yasuhisa Kimura; Atsushi Kodan; Michinori Matsuo; Kazumitsu Ueda
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

7.  Bile salt-stimulated phospholipid efflux mediated by ABCB4 localized in nonraft membranes.

Authors:  Shin-ya Morita; Tadanori Tsuda; Manami Horikami; Reiko Teraoka; Shuji Kitagawa; Tomohiro Terada
Journal:  J Lipid Res       Date:  2013-03-06       Impact factor: 5.922

8.  Structure of the human lipid exporter ABCB4 in a lipid environment.

Authors:  Jeppe A Olsen; Amer Alam; Julia Kowal; Bruno Stieger; Kaspar P Locher
Journal:  Nat Struct Mol Biol       Date:  2019-12-23       Impact factor: 15.369

Review 9.  Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.

Authors:  Shin-ya Morita; Tomohiro Terada
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

Review 10.  P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease.

Authors:  Iman Imtiyaz Ahmed Juvale; Azzmer Azzar Abdul Hamid; Khairul Bariyyah Abd Halim; Ahmad Tarmizi Che Has
Journal:  Heliyon       Date:  2022-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.